Equities

Organovo Holdings Inc

Organovo Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.4964
  • Today's Change-0.011 / -2.09%
  • Shares traded90.48k
  • 1 Year change-66.91%
  • Beta0.6156
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments2.901629
Total Receivables, Net0.030.15--
Total Inventory0.30----
Prepaid expenses0.700.890.86
Other current assets, total0.00----
Total current assets3.941730
Property, plant & equipment, net1.972.612.82
Goodwill, net------
Intangibles, net0.010.010.09
Long term investments------
Note receivable - long term------
Other long term assets0.290.500.71
Total assets6.352033
LIABILITIES
Accounts payable0.630.330.42
Accrued expenses1.233.340.97
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total------
Total current liabilities1.863.671.38
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total0.891.311.70
Total liabilities2.754.983.09
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital343340338
Retained earnings (accumulated deficit)(340)(325)(308)
Treasury stock - common0.000.000.00
Unrealized gain (loss)------
Other equity, total00.00--
Total equity3.601530
Total liabilities & shareholders' equity6.352033
Total common shares outstanding108.728.71
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.